Mn Services Vermogensbeheer B.V. Abb Vie Inc. Transaction History

Mn Services Vermogensbeheer B.V.

$14.3 Billion
Q3 2024

A detailed history of Mn Services Vermogensbeheer B.V. transactions in Abb Vie Inc. stock. As of the latest transaction made, Mn Services Vermogensbeheer B.V. holds 684,204 shares of ABBV stock, worth $125 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares

684,204

Previous 697,804 1.95%

Holding current value

$125 Million

Previous $120 Million 12.89%

% of portfolio

0.95%

Previous 0.86%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$163.84 - $199.33 $2.23 Million - $2.71 Million	-13,600 Reduced 1.95%	684,204 $135 Million
Q2 2024 Jul 25, 2024	SELL	$154.79 - $180.76 $2.77 Million - $3.24 Million	-17,900 Reduced 2.5%	697,804 $120 Million
Q1 2024 Apr 29, 2024	SELL	$159.82 - $182.1 $19.4 Million - $22.1 Million	-121,200 Reduced 14.48%	715,704 $130 Million
Q4 2023 Jan 29, 2024	SELL	$137.6 - $154.97 $2.81 Million - $3.16 Million	-20,400 Reduced 2.38%	836,904 $130 Million
Q3 2023 Oct 25, 2023	BUY	$133.59 - $154.65 $1.94 Million - $2.24 Million	14,500 Added 1.72%	857,304 $128 Million
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $4.94 Million - $6.15 Million	-37,300 Reduced 4.24%	842,804 $114 Million
Q1 2023 Apr 26, 2023	BUY	$144.61 - $166.54 $4.4 Million - $5.06 Million	30,400 Added 3.58%	880,104 $140 Million
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $18.3 Million - $21.9 Million	-132,000 Reduced 13.45%	849,704 $137 Million
Q3 2022 Nov 01, 2022	SELL	$134.21 - $153.93 $8.27 Million - $9.48 Million	-61,600 Reduced 5.9%	981,704 $132 Million
Q2 2022 Aug 03, 2022	SELL	$137.62 - $174.96 $30.3 Million - $38.6 Million	-220,400 Reduced 17.44%	1,043,304 $160 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $11.1 Million - $13.7 Million	-83,900 Reduced 6.23%	1,263,704 $205 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $3.16 Million - $4 Million	29,400 Added 2.23%	1,347,604 $182 Million
Q3 2021 Nov 03, 2021	BUY	$106.4 - $120.78 $2.47 Million - $2.8 Million	23,200 Added 1.79%	1,318,204 $142 Million
Q2 2021 Aug 05, 2021	SELL	$105.21 - $117.21 $27.3 Million - $30.4 Million	-259,400 Reduced 16.69%	1,295,004 $123 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $1.54 Million - $2.08 Million	19,100 Added 1.24%	1,554,404 $167 Million
Q3 2020 Nov 04, 2020	BUY	$85.91 - $100.83 $2.6 Million - $3.06 Million	30,300 Added 2.01%	1,535,304 $134 Million
Q2 2020 Jul 23, 2020	BUY	$73.37 - $98.18 $17.7 Million - $23.7 Million	241,300 Added 19.09%	1,505,004 $148 Million
Q1 2020 May 12, 2020	SELL	$64.5 - $97.79 $5.06 Million - $7.68 Million	-78,500 Reduced 5.85%	1,263,704 $96.3 Million
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $3.18 Million - $3.98 Million	44,100 Added 3.4%	1,342,204 $119 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $34.2 Million - $41.1 Million	543,010 Added 71.91%	1,298,104 $98.3 Million
Q2 2019 Jul 25, 2019	SELL	$65.7 - $83.98 $5.49 Million - $7.01 Million	-83,500 Reduced 9.96%	755,094 $54.9 Million
Q1 2019 May 06, 2019	BUY	$77.14 - $90.79 $347,130 - $408,555	4,500 Added 0.54%	838,594 $67.6 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $46.1 Million - $56.9 Million	592,404 Added 245.11%	834,094 $67.3 Million
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $843,932 - $998,562	-9,400 Reduced 3.74%	241,690 $22.4 Million
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $230,025 - $308,025	2,500 Added 1.01%	251,090 $23.8 Million
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $1.24 Million - $1.37 Million	-13,900 Reduced 5.3%	248,590 $20 Million
Q3 2017 Nov 01, 2017	BUY	$69.85 - $89.22 $18.3 Million - $23.4 Million	262,490	262,490 $23.3 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $323B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.

Account

Mn Services Vermogensbeheer B.V. Abb Vie Inc. Transaction History